Morgan Stanley Reiterates Overweight on NOV, Maintains $22 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Elizabeth Porter has reiterated an Overweight rating on NOV (NYSE:NOV) and maintained a $22 price target.
July 17, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley has reiterated an Overweight rating on NOV and maintained a $22 price target, indicating a positive outlook for the company.
The reiteration of an Overweight rating by Morgan Stanley indicates a positive outlook for NOV. The maintained price target of $22 suggests that the analyst believes the stock is undervalued at current prices, which could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100